Active Ingredient History
Durvalumab, sold under the brand name Imfinzi, is an FDA-approved immunotherapy for cancer, developed by Medimmune/AstraZeneca. It is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 (CD279). Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Angiogenesis Modulating Agents (Phase 2)
Anus Neoplasms (Phase 2)
Appendiceal Neoplasms (Phase 1/Phase 2)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 3)
BRCA1 Protein (Phase 2)
Breast (Phase 1/Phase 2)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Merkel Cell (Phase 1/Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Pancreatic Ductal (Phase 1)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2/Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Castration (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Cholangiocarcinoma (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Digestive System Diseases (Phase 1)
DNA Mismatch Repair (Phase 2)
DNA Repair-Deficiency Disorders (Phase 2)
Drugs, Investigational (Phase 4)
Dysgerminoma (Phase 2)
Endometrial Neoplasms (Phase 3)
Epstein-Barr Virus Infections (Phase 2)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagogastric Junction (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Fibrosis (Phase 2)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Neoplasms (Phase 3)
Genital Neoplasms, Female (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hematologic Neoplasms (Phase 1/Phase 2)
HIV (Phase 2)
Hormones (Phase 2)
Human papillomavirus 16 (Phase 2)
Hydronephrosis (Early Phase 1)
Hypertension, Portal (Phase 2)
Hypopharyngeal Neoplasms (Phase 2/Phase 3)
Hypopharynx (Phase 2)
Immunotherapy (Phase 2)
Infusions, Intravenous (Phase 4)
Intestinal Neoplasms (Phase 1)
Kidney Neoplasms (Phase 2)
Klatskin Tumor (Phase 2)
Laryngeal Neoplasms (Phase 2/Phase 3)
Larynx (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lip (Phase 1)
Lip Neoplasms (Phase 2)
Liposarcoma (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 1/Phase 2)
Lymphoma, Follicular (Phase 1/Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 1)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 1/Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 1/Phase 2)
Melanoma (Phase 2)
Menopause (Phase 2)
Mesothelioma (Phase 3)
Mesothelioma, Malignant (Phase 3)
Microsatellite Instability (Phase 2)
Mouth Neoplasms (Phase 2/Phase 3)
Multiple Myeloma (Phase 2)
Mutation (Phase 2)
Mycosis Fungoides (Phase 1/Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 4)
Neoplasms ()
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neuroendocrine Tumors (Phase 2)
Oropharyngeal Neoplasms (Phase 3)
Oropharynx (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Diseases (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Papillomavirus Infections (Phase 2)
Penile Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Plasmacytoma (Phase 1)
Polycythemia Vera (Phase 1)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 2)
Radiotherapy (Phase 2)
Rare Diseases (Phase 2)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 2)
Sarcoma (Phase 3)
Seminoma (Phase 2)
Sepsis (Phase 2)
Sezary Syndrome (Phase 1/Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Smoldering Multiple Myeloma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 2)
Testicular Neoplasms (Phase 2)
Thoracic Neoplasms (Phase 2)
Thyroid Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Ureteral Neoplasms (Early Phase 1)
Urethral Neoplasms (Early Phase 1)
Urinary Bladder Diseases (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uterine Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Vulvar Neoplasms (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
